Improvements in sensor accuracy, greater convenience and ease of use, and expanding
reimbursement have led to growing adoption of continuous glucose monitoring (CGM) …

Aims Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely
manner according to evidence‐based clinical guidelines, is a key reason for uncontrolled …

Background Consensus guidelines recommend multi-modal chronic pain treatment with
increased uptake of non-pharmacological pain treatment modalities (NPMs). We aimed to …

Many people with type 2 diabetes mellitus (T2DM) fail to achieve glycaemic control promptly
after diagnosis and do not receive timely treatment intensification. This may be in part due to …

Hypertension is one of the most important risk factors that contribute to incident
cardiovascular events. A multitude of US and international hypertension guidelines …

Objective: To evaluate the use of existing practice control groups in randomized controlled
trials of behavioral interventions and the role of extrinsic health care services in the design …

Early glycaemic control leads to better outcomes, including a reduction in long-term
macrovascular and microvascular complications. Despite good-quality evidence, glycaemic …

Diabetes mellitus is a chronic disease characterized by high social, economic and health
burden, mostly due to the high incidence and morbidity of diabetes complications …

Good quality randomised controlled trials and systematic reviews have shown that
management of risk factors such as blood pressure, dyslipidemia and glucose control can …

Background Therapeutic inertia has been defined as the failure of health-care provider to
initiate or intensify therapy when therapeutic goals are not reached. It is regarded as a major …